Irregular functioning of humans immune system leads in autoimmune disorders. Overproduction of self-reactive immune cells (such as antibodies & T-cells) damage regular functions of /cells/tissues/organs. This result in different autoimmune disorders such as rheumatoid arthritis, systemic lupus erythematosus, multiple sclerosis, and others diseases. Typically, drugs are used as a treatment for autoimmune disorders. The adverse effects associated with drugs has made switched to concentrate on monoclonal antibodies.
Monoclonal antibodies have the ability to offer more efficient therapeutic and less toxic alternatives to treat autoimmune diseases. Recent years have seen the emergence of monoclonal antibodies being used to treat wide array of diseases that are related to immune response. These antibodies are mono-specific comprising of identical immune cells which are clones of a single parent cell and are directed towards a particular cellular target. Thus monoclonal antibodies due to its customizable nature can be used to treat the self-reactive immune cells not impacting the normal ones.
Key factors which affect and thereby cause changes to the market dynamics are studied essentially and are presented in a well-known way in the report. Some of those factors are
Rising involvement of public & private organizations to support advanced therapeutics development, growing healthcare expenditure, and increasing number of population
Lack of awareness among patients about advanced therapies, high cost of monoclonal antibodies therapeutics and underdeveloped healthcare infrastructure
For granular level understanding the Autoimmune Monoclonal Antibodies Market is segmented based on Source, Application, and End User, each being provided with Market Size Estimations and Y-o-Y Forecasts.
Based on Source: Murine Chimeric Humanized Human
Based on Application: Systemic Lupus Erythematosus Rheumatoid Arthritis Multiple Sclerosis Transplant Rejection/Graft Versus Host Disease Others
Based on End User: Hospitals/Clinics Research Institute Diagnostic Laboratories
On the basis of geographical areas, Middle-East & Africa Autoimmune Monoclonal Antibodies market is segmented as Middle-East and Africa. Some of the key players that operate in the Middle-East and Africa Autoimmune Monoclonal Antibodies Market include GlaxoSmithKline plc (U.K.), UCB Company (Belgium), F. Hoffmann-La Roche Ltd. (Switzerland), Bristol-Myers Squibb (U.S.), AstraZeneca plc (U.K.), Takeda Pharmaceutical Company Ltd. (Japan), Johnson & Johnson (U.S.), Biogen Inc.(U.S.), Amgen Inc. (U.S.), and Innovent Biologics, Inc. (China).
The incremental acceptance in monoclonal antibody products across the U.S. and Europe have also granted to soaring revenue of the global market. The report by TMR suggests that about five to six monoclonal antibodies are accepted each year in these regions. 48 have hit the market out of the 60 monoclonal antibodies approved in Europe in 2015. Thus, the broadening product portfolio that comes in a broad price range has also played a major role in encouraging the uptake of monoclonal antibody therapeutics.
The Middle-East and Africa Autoimmune Monoclonal Antibodies Market report offers wide-range of scope:
Regional level analysis that provides an individual perspective of Middle-East and Africa region individually and on a whole
Know more about key areas of industry growth via detailed Segment-level analysis on basis of Source, Application, and End User along with market size forecasts and y-o-y estimations
Detailed explanation of major drivers, restraints, opportunities, and challenges (DROC) that affect the market and impact the ever-shifting market dynamics
Strategic Analyses containing PESTLE and Porters Five Forces Analyses which are obtained by studying the macro & micro environmental factors that affect the market demographics
Comprehensive listing of key market players along with Company overview, product portfolios, financials (subjected to availability), SWOT analysis and analyst overview
Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
Market Outlook - Investment opportunities devised by stand in experts to provide both individuals and organizations a strong financial foothold in the market
For more reports related to the Therapeutics Market:
About Market Data Forecast: Market Data Forecast is one of the prominent market research companies which offers syndicated as well as customized research services to individual or corporate clients. Their syndicated research reports contain Market Sizing and forecasts for 5-year period with a niche level of segmentation providing you with more focused insights whereas the consult research services can fetch the distinctive data requirements at competitive industry costs. For more info kindly visit, www.marketdataforecast.com
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including:
